Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device
May 17, 2022 06:04 ET
|
Zealand Pharma
Company announcement – No. 21 / 2022 Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device Deal includes $10 million USD upfront payment to...
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED]
May 12, 2022 16:05 ET
|
Zealand Pharma
Company announcement – No. 20/ 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED] Copenhagen, DK and Boston, MA, May 12, 2022 –...
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities
May 12, 2022 12:05 ET
|
Zealand Pharma
Company announcement – No. 19 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, May 12, 2022 – Zealand Pharma...
Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022
May 10, 2022 16:05 ET
|
Zealand Pharma
Company announcement – No. 17 / 2022 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 Copenhagen, DK and Boston, MA, May 10 2022 – Zealand Pharma A/S (“Zealand”)...
Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy
May 09, 2022 21:17 ET
|
Zealand Pharma
Company announcement – No. 16/ 2022 Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy Amendment reduces the outstanding note principal balance...
Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022
May 05, 2022 04:00 ET
|
Zealand Pharma
Company announcement – No. 15 / 2022 Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022 Copenhagen, DK and Boston, MA, U.S. May 5,...
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities
April 22, 2022 11:00 ET
|
Zealand Pharma
Company announcement – No. 15 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, April 22, 2022 – Zealand Pharma...
Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022
April 20, 2022 16:30 ET
|
Zealand Pharma
Company announcement – No. 14 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022 Copenhagen, DK and Boston, MA, US., April 20, 2022 – Zealand Pharma...
Correction: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022
April 07, 2022 10:18 ET
|
Zealand Pharma
Company announcement – No. 13 / 2022 CORRECTION: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022 Copenhagen, DK and Boston, MA, April 7, 2022 – Zealand Pharma A/S...
Zealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022
April 07, 2022 03:00 ET
|
Zealand Pharma
Company announcement – No. 13 / 2022 Zealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022 Copenhagen, DK and Boston, MA, April 7, 2022 – Zealand Pharma A/S...